Drugs Made In America Acquisition swings to Q1 FY26 profit of $1.97 million

Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp.

DMAA

0.00
  • Drugs Made In America Acquisition posted net income of $1.97 million for the quarter ended March 31, 2026, up 57.06% from a year earlier.
  • Interest earned on cash and investments held in the trust account rose to $2.11 million, while general and administrative costs fell to $143,301.
  • Cash on hand totaled $14,887 as of March 31, 2026.
  • Company entered a definitive merger agreement on April 29, 2026 with Power Analytics Global Corporation, targeting a Nasdaq-listed combined company.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drugs Made In America Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-056798), on May 14, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.